MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$39,621K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sale of prv, net
Proceeds from maturities of inve...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Gain from sale of prv, net
Purchases of investments
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
123,214
-47,594
-42,538
-50,332
Depreciation and amortization of property and equipment
1,564
1,608
1,678
2,702
Amortization of finance lease right of use asset
539
538
539
538
Impairment of operating lease right-of-use asset
-
-
262
-
Stock-based compensation
7,419
8,493
6,112
9,759
Accretion of discount on investments, net
643
1,020
1,088
1,599
Change in fair value of warrant liabilities
-
-
0
0
Gain from sale of prv, net
178,190
-
-
-
Prepaid expenses and other assets
355
1,643
-1,150
-739
Accounts payable and accrued expenses
4,699
-5,749
-967
-12,247
Operating lease liabilities and right of use assets, net
-27
-29
11
12
Finance lease liability
0
0
2
8
Other liabilities
67
2
-1
0
Net cash used in operating activities
-39,613
-45,394
-34,840
-50,420
Proceeds from sale of prv, net
178,190
-
-
-
Purchases of investments
14,822
48,709
54,495
29,438
Proceeds from maturities of investments
51,000
66,250
91,000
123,000
Purchases of property and equipment
8
93
80
-54
Net cash provided by (used in) investing activities
214,360
17,448
36,425
93,616
Issuance of common stock, net of issuance costs-Public Offering
-
-
0
-
Issuance of common stock pursuant to exercise of stock options
152
-
0
0
Return of related party short-swing profits
0
-
0
0
Repurchase of restricted stock units to satisfy tax withholding
-
-
0
67
Finance lease liability
2
1
-
-
Net cash provided by financing activities
150
-1
0
-67
Net change in cash, cash equivalents and restricted cash
174,897
-27,947
1,585
43,129
Cash, cash equivalents and restricted cash at beginning of period
50,951
78,898
77,313
164,997
Cash, cash equivalents and restricted cash at end of period
225,848
50,951
78,898
77,313
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of prv,
net
$178,190K
Proceeds from maturities
of investments
$51,000K
(-69.42%↓ Y/Y)
Issuance of common stock
pursuant to exercise of...
$152K
Net cash provided by
(used in) investing...
$214,360K
(915.86%↑ Y/Y)
Net cash provided by
financing activities
$150K
(-30.23%↓ Y/Y)
Canceled cashflow
$14,830K
Canceled cashflow
$2K
Net change in cash,
cash equivalents and...
$174,897K
(233.70%↑ Y/Y)
Canceled cashflow
$39,613K
Purchases of investments
$14,822K
(-92.31%↓ Y/Y)
Purchases of property and
equipment
$8K
(-98.07%↓ Y/Y)
Net income (loss)
$123,214K
(194.60%↑ Y/Y)
something is missing
$11,498K
Stock-based compensation
$7,419K
(-64.98%↓ Y/Y)
Depreciation and
amortization of property and...
$1,564K
(-65.17%↓ Y/Y)
Amortization of finance lease
right of use asset
$539K
(-49.95%↓ Y/Y)
Other liabilities
$67K
(183.75%↑ Y/Y)
Finance lease liability
$2K
(-92.00%↓ Y/Y)
Net cash used in
operating activities
-$39,613K
(62.18%↑ Y/Y)
Canceled cashflow
$144,301K
Gain from sale of prv,
net
$178,190K
Accounts payable and
accrued expenses
$4,699K
(64.13%↑ Y/Y)
Accretion of discount on
investments, net
$643K
(-85.00%↓ Y/Y)
Prepaid expenses and
other assets
$355K
(277.50%↑ Y/Y)
Operating lease
liabilities and right of use...
-$27K
(-222.73%↓ Y/Y)
Buy us a coffee
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)